Marc Tessier-Lavigne

Marc Tessier-Lavigne is the founder of Xaira Therapeutics. Xaira Therapeutics has raised $1B, latest Series A $1B (2024). Biotech · South San Francisco, CA.

About Marc Tessier-Lavigne

Marc Tessier-Lavigne is the founder of Xaira Therapeutics. Xaira Therapeutics operates in Biotech and is based in South San Francisco, CA. Xaira Therapeutics has raised $1B, latest Series A $1B (2024). Backers on record include Roy Erez, R-Squared Ventures.

Marc Tessier-Lavigne at a glance

Company
Xaira Therapeutics
Industry
Biotech
Location
South San Francisco, CA
Total raised
$1B
Investors on record
Roy Erez, R-Squared Ventures

Frequently asked about Marc Tessier-Lavigne

Who is Marc Tessier-Lavigne?
Marc Tessier-Lavigne is the founder of Xaira Therapeutics. Full profile, funding history and background on StartupFundraising.com.
What company did Marc Tessier-Lavigne found?
Marc Tessier-Lavigne founded Xaira Therapeutics, a Biotech company based in South San Francisco, CA.
How do I contact Marc Tessier-Lavigne?
Verified contact routes including LinkedIn, background and funding history for Marc Tessier-Lavigne are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in South San Francisco — who backed them, at what stage, and how much they raised.

Xaira Therapeutics funding profile (1)

More Biotech founders (40)

Browse related founder lists (5)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades